BDX 1.92% 13.3¢ bcal diagnostics limited

Ann: Change in substantial holding, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,867 Posts.
    lightbulb Created with Sketch. 981
    There is zero promotion of this stock. No webinars, conferences etc No LinkedIn promotion.

    The MD lives in the USA and the Executive Chairman and major shareholder Jayne Shaw is not one for small talk and has many business interests including the Sydney Breast Clinic which is an easy leg up for the BCAL blood test when operational later next year.

    Commercialisation in less than 12 months in Australia.

    BDX will be one of those stocks that will one day multibag out of the blue and investors sitting on the sidelines will wonder why they were not on board as it was so obvious. This day will come in 2024 imo.
 
watchlist Created with Sketch. Add BDX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.